19/05/2022
Circulating vaccine-derived poliovirus, nOPV2, Outbreak countries
Afghanistan, Africa, India, Pakistan
Coffee With Polio Experts: Dr Ananda Bandyopadhyay
Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance
In this two-part video series, we chat with Dr Ananda Bandyopadhyay, Deputy Director of Polio Technology, Research & Analytics, BMGF, about the new tool in GPEI’s kit to combat cVDPV2: novel oral polio vaccine type 2 (nOPV2).
Related News
19/07/2024
Circulating variant type 2 poliovirus (cVDPV) has been confirmed in the Gaza Strip. Virus was isolated from six environmental (sewage) samples, collected from two different collection sites in two sub-regions within Gaza, collected on 23 June 2024.
06/06/2024
Advocating for a Polio-Free Future for Every Child
26/04/2024
President and First Lady meet with GPEI delegation to discuss measures to increase immunity levels
11/03/2024
Women play central, diverse and multifaceted roles in safeguarding children from polio, proving that investments in women’s capacities and skills translate into investments in strengthening health systems.
